10 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
2 Feb 24
FDA Issues Reminder of Non-Substitution of PEDMARKÒ (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
12:00am
as a separate vial in some products; it is not present in PEDMARK.
The public communication was issued by the FDA’s Professional Affairs and Stakeholder
424B3
FENC
Fennec Pharmaceuticals Inc
4 Apr 13
Prospectus supplement
12:00am
and investment background, as a designee of one of the Company’s largest investors, he brings to the Board the perspective of a major stakeholder.
Chris
POS AM
FENC
Fennec Pharmaceuticals Inc
1 Apr 13
Prospectus update (post-effective amendment)
12:00am
of a major stakeholder.
Chris A. Rallis
Mr. Chris A. Rallis has served as a director of Adherex since August 2011. Mr. Rallis has been an executive
424B3
2ig54x10pr
14 Feb 11
Prospectus supplement
12:00am
S-1/A
qv3dnswbz t25
9 Feb 11
IPO registration (amended)
12:00am
CORRESP
g7k62pz1wa j9
12 Jan 11
Correspondence with SEC
12:00am
- Prev
- 1
- Next